Purpose: We assessed the erectile responses and adverse reactions to prosta
glandin E-1 delivered via the medicated urethral system for erection (MUSE)
in a titration study to determine optimal dose.
Methods: Sixty-four patients with erectile dysfunction underwent ill-office
testing with MUSE to determine erectile response. Following thorough instr
uctions, patients were taught how to use MUSE themselves. The titration stu
dy started with a dose of 125 mug, and increased to 250 mug, 500 mug, and f
inally 1,000 mug. Tn patients who had an erectile response, erection scorin
g, color duplex Doppler study, blood pressure monitoring, recording of subj
ective complaints, and repeated laboratory examinations were performed to e
valuate the positive and adverse effects of MUSE.
Results: Forty-three of the 64 patients achieved a maximal erection with MU
SE, as shown by systolic peak flow velocities in the deep penile arteries o
f greater than 27 cm/s on Doppler ultrasonography. One patient was unsatisf
ied with his erectile response and dropped out of the study. Of the 49 pati
ents who completed the study, most (35) were satisfied with the response ac
hieved at the higher doses of 500 mug and 1,000 mug. A modified soft rubber
band was needed to achieve a satisfactory erectile response in 18 patients
. Only four patients experienced serious urethral burning during MUSE appli
cation.
Conclusions: MUSE was effective and safe in most patients with erectile dys
function in this study. For patients not satisfied with the extent of penil
e rigidity achieved with MUSE, the use of a modified soft rubber band for e
rectile assistance, as well as a program for improved patient education, ma
y help to achieve a better erectile response and facilitate compliance with
treatment regimens at home.